A concerning shortage of Adderall, one of the drugs commonly used to treat attention deficit hyperactivity disorder (ADHD), is putting patients at risk. What caused it, and how can we fix it? The EPA has set new guidelines to keep PFAS out of drinking water. There's a problem, however: the agency's standards are absurd.
The shortage of Adderall, an important medication used to treat ADHD – attention deficit/hyperactivity disorder – is a story of supply, demand, the invisible hand of market forces. It’s also about a bureaucracy focused on regulation rather than outcome. It has all the hallmarks of the opioid crisis. We have learned nothing.
In today's "just when you think it can't get any worse" feature, DEA agents are now seizing counterfeit Adderall pills that contain pure methamphetamine. Although Mexican drug cartels are blamed for making these pills to get young people addicted to meth, the ultimate blame falls on DEA policies. What a mess.
A.D.H.D., once thought of as a disorder that affects only children and young adults, may not fade nor disappear in adulthood, which is why a doctor at Johns Hopkins believes it may affect the elderly as well.